Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan
Pharmacoepidemiology and Drug Safety, 10/27/09
Matsushita Y et al. – Pravastatin did not increase the rate of cancer incidence or cancer death in a large population of Japanese patients followed for >70 000 patient–years.
Related Articles
Pravastatin and cardiovascular risk in moderate chronic kidney disease
Atherosclerosis, 10/07/09
Relevance Score: 88%
Review: statins do not protect against development of dementia
Evidence-Based Mental Health, 10/30/09
Relevance Score: 80%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
N2 Disease in Patients With Head and Neck Squamous Cell Cancer Treated With Chemoradiotherapy
Archives of Otolaryngology, 11/24/09
Valproic acid restores ERalpha and antiestrogen sensitivity to ERalpha-negative breast cancer cells
Molecular and Cellular Endocrinology, 11/24/09
Salvage treatment with upfront melphalan 100 mg/m2 and consolidation with novel drugs for fulminant progression of multiple myeloma
Annals of Hematology, 11/24/09
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials
PharmacoEconomics, 11/24/09
Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09
Sponsor
Article Search
Sponsor


See Latest Articles


